Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome

Blood

Volumn 89, Issue 11, 1997, Pages 4161-4166

  Kees, Ursula R ^a   Burton, Paul R ^b   Lü, Changlong ^b   Baker, David L ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P16;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CHILD; CHROMOSOME 9P; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GENE DELETION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE COUNT; MALE; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RISK FACTOR; SOUTHERN BLOTTING; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

EID: 0030941813     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.11.4161     Document Type: Article

References (36)

1. Pollak C, Hagemeijer A: Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia 1:541, 1987
2. Olopade OL, Bohlander SK, Pomykala H, Maltepe E, Van Melle E, Le Beau MM, Diaz MO: Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 14:437, 1992
3. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753, 1994
4. Kamb A, Gruis NA, Weaver-Feldhaus J, et al: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436, 1994
5. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704, 1993
6. Kamb A: Cell-cycle regulators and cancer. Trends Genet 11:136, 1995
7. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H: Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 84:2431, 1994
8. INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood 84:4038, 1994
9. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P: P16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 85:657, 1995
10. INK4A) deletion in primary tumor cells of 163 leukemic patients. Blood 85:854, 1995
11. Otsuki T, Clark HM, Wellmann A, Jaffe ES, Raffeld M: Involvement of cdkn2 (p16(ink4a)/mts1) and p15(ink4b)/mts2 in human leukemias and lymphomas. Cancer Res 55:1436, 1995
12. Cayuela JM, Madani A, Sanhes L, Stern MH, Sigaux F: Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 87:2180, 1996
13. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 85:2321, 1995
14. Rasool O, Heyman M, Brandter LB, Liu Y, Grander D, Soderhall S, Einhorn S: p15(ink4b) and p16(ink4) gene inactivation in acute lymphocytic leukemia. Blood 85:3431, 1995
15. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen J, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler HP: Analysis of a family of cyclin-dependent kinase inhibitors - p15/mts2/ink4b, p16/mts1/ink4a, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 86:755, 1995
16. Ogawa S, Hangaishi A, Miyawaki S, Hirosawa S, Miura Y, Takeyama K, Kamada N, Ohtake S, Uike N, Shimazaki C, Toyama K, Hirano M, Mizoguchi H, Kobayashi Y, Furusawa S, Saito M, Emi N, Yazaki Y, Ueda R, Hirai H: Loss of the cyclin-dependent kinase 4-inhibitor (p16-mts1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood 86:1548, 1995
17. Ohnishi H, Kawamura M, Ida K, Sheng XM, Hanada R, Nobori T, Yamamori S, Hayashi Y: Homozygous deletions of p 16/ MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood 86:1269, 1995
18. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27, 1996
19. INK4 gene inactivation in childhood acute lymphocytic leukemia. J Clin Oncol 14:1512, 1996
20. Fizzotti M, Cimino G, Pisegna S, Alimena G, Quartarone C, Mandelli F, Pelicci PG, Lococo F: Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 85:2685, 1995
21. Kees UR, Ranford PR, Hatzis M: Deletion of the p16 gene in pediatric leukemia and corresponding cell lines. Oncogene 12:2235, 1996
22. Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD: Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Children's Cancer Group phase III trial. J Clin Oncol 11:527, 1993
23. Steinherz PG, Gaynon P, Miller DR, Reaman G, Bleyer A, Finkelstein J, Evans RG, Meyers P, Steinherz LJ, Sather H, Hammond D: Improved disease-free survival of children wilh acute lymphoblastic leukemia at high risk for early relapse with the New York regimen - A new intensive therapy protocol: A report from the Children's Cancer Study Group. J Clin Oncol 4:744, 1986
24. Miller DR, Coccia PF, Bleyer WA, Lukens JN, Siegel SE, Sather HN, Hammond GD: Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: A report from the Children's Cancer Study Group. J Clin Oncol 7:1807, 1989
25. Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finkelstein JZ, Grossman NJ, Novak LJ, Pyesmany AF, Reaman GH, Chappell RJ, Sather HN, Hammond GD: Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: A follow-up report of the Children's Cancer Group Study CCG-106. J Clin Oncol 11:2234, 1993
26. Kees UR, Lukeis R, Ford J, Garson OM: Establishment and characterization of a childhood T-cell acute lymphoblastic leukemia cell line, PER-255, with chromosome abnormalities involving 7q32-34 in association with T-cell receptor-beta gene rearrangement. Blood 74:369, 1989
27. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory. 1989
28. Salvati PD, Peroni SE, Ranford PR, Kees UR: Requirements for the induction of the interleukin-2 receptor complex in a human pre-T-cell line. Immunology 78:449, 1993
29. Gonzalez-Redondo JM, Stoming TA, Lanclos KD, Gu YC, Kutlar A, Kutlar F, Nakatsuji T, Deng B, Han IS, McKie VC, Huisman THJ: Clinical and genetic heterogeneity in black patients with homozygous β-thalassemia from the southeastern United States. Blood 72:1007, 1988
30. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
31. Miller GM, Gong G, Munoz A: Survival Analysis. New York, NY, Wiley, 1981
32. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34:187, 1972
33. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui C-H, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18, 1996
34. McCullagh P, Nelder JA: Generalized Linear Models (ed 2). London, UK, Chapman & Hall, 1989
35. Clayton DG, Hills M: Statistical Models in Epidemiology. Oxford, UK, Oxford University Press, 1993
36. Pui CH: Childhood leukemias. N Engl J Med 332:1618, 1995